Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

587 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.
Schuppan D, Schattenberg JM. Schuppan D, et al. J Gastroenterol Hepatol. 2013 Aug;28 Suppl 1:68-76. doi: 10.1111/jgh.12212. J Gastroenterol Hepatol. 2013. PMID: 23855299 Review.
Modulation of collagen XVIII/endostatin expression in lobular and biliary rat liver fibrogenesis.
Jia JD, Bauer M, Sedlaczek N, Herbst H, Ruehl M, Hahn EG, Riecken EO, Schuppan D. Jia JD, et al. Among authors: schuppan d. J Hepatol. 2001 Sep;35(3):386-91. doi: 10.1016/s0168-8278(01)00134-9. J Hepatol. 2001. PMID: 11592600
Early inflammatory players in cutanous fibrosis.
Raker V, Haub J, Stojanovic A, Cerwenka A, Schuppan D, Steinbrink K. Raker V, et al. Among authors: schuppan d. J Dermatol Sci. 2017 Sep;87(3):228-235. doi: 10.1016/j.jdermsci.2017.06.009. Epub 2017 Jun 15. J Dermatol Sci. 2017. PMID: 28655471 Review.
Inducible knockdown of procollagen I protects mice from liver fibrosis and leads to dysregulated matrix genes and attenuated inflammation.
Molokanova O, Schönig K, Weng SY, Wang X, Bros M, Diken M, Ohngemach S, Karsdal M, Strand D, Nikolaev A, Eshkind L, Schuppan D. Molokanova O, et al. Among authors: schuppan d. Matrix Biol. 2018 Mar;66:34-49. doi: 10.1016/j.matbio.2017.11.002. Epub 2017 Nov 6. Matrix Biol. 2018. PMID: 29122677
Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in Germany.
Labenz C, Huber Y, Kalliga E, Nagel M, Ruckes C, Straub BK, Galle PR, Wörns MA, Anstee QM, Schuppan D, Schattenberg JM. Labenz C, et al. Among authors: schuppan d. Aliment Pharmacol Ther. 2018 Nov;48(10):1109-1116. doi: 10.1111/apt.14976. Epub 2018 Oct 4. Aliment Pharmacol Ther. 2018. PMID: 30288767
Serum endotrophin identifies optimal responders to PPARγ agonists in type 2 diabetes.
Karsdal MA, Henriksen K, Genovese F, Leeming DJ, Nielsen MJ, Riis BJ, Christiansen C, Byrjalsen I, Schuppan D. Karsdal MA, et al. Among authors: schuppan d. Diabetologia. 2017 Jan;60(1):50-59. doi: 10.1007/s00125-016-4094-1. Epub 2016 Sep 8. Diabetologia. 2017. PMID: 27631136 Clinical Trial.
Hepatocellular carcinoma in nonalcoholic fatty liver disease: A link between oxidative stress and T-cell suppression.
Qureshi MA, Kim YO, Schuppan D. Qureshi MA, et al. Among authors: schuppan d. Hepatology. 2016 Nov;64(5):1794-1797. doi: 10.1002/hep.28815. Hepatology. 2016. PMID: 27629157 No abstract available.
Podoplanin discriminates distinct stromal cell populations and a novel progenitor subset in the liver.
Eckert C, Kim YO, Julich H, Heier EC, Klein N, Krause E, Tschernig T, Kornek M, Lammert F, Schuppan D, Lukacs-Kornek V. Eckert C, et al. Among authors: schuppan d. Am J Physiol Gastrointest Liver Physiol. 2016 Jan 1;310(1):G1-12. doi: 10.1152/ajpgi.00344.2015. Epub 2015 Nov 12. Am J Physiol Gastrointest Liver Physiol. 2016. PMID: 26564718 Free PMC article.
Traditional Chinese Medicine (TCM) for fibrotic liver disease: hope and hype.
Zhang L, Schuppan D. Zhang L, et al. Among authors: schuppan d. J Hepatol. 2014 Jul;61(1):166-8. doi: 10.1016/j.jhep.2014.03.009. Epub 2014 Apr 26. J Hepatol. 2014. PMID: 24780816 Review. No abstract available.
Evolving therapies for liver fibrosis.
Schuppan D, Kim YO. Schuppan D, et al. J Clin Invest. 2013 May;123(5):1887-901. doi: 10.1172/JCI66028. Epub 2013 May 1. J Clin Invest. 2013. PMID: 23635787 Free PMC article. Review.
587 results
Jump to page